Karnataka businessman killed, wife critically injured in Dubai road mishap

Mangaluru, Apr 5: As the number of Covid 19 cases continue to spike across Karnataka, there are patients who are recovering from this deadly virus as well. The first case of Covid 19 detected in Mangaluru has fully recovered and all set to return home.

The first case of corona infection was reported on March 22 in Dakshina Kannada district. 

A 22-year-old youth hailing from Bhatkal had landed at Mangaluru International Airport on March 19. 

As he was suffering from mild fever and cold, he was quarantined in Mangaluru. He had come from Dubai.

His throat swabs were sent for testing on the same day and on March 22 he was tested positive for coronavirus. 

He has undergone 14-day long treatment at the Wenlock Hospital, Mangaluru. 

On April 2 and 3, his throat swabs were sent for testing again. Both times he was tested negative for coronavirus. He is expected to be discharged on April 6.

So far a dozen coronavirus positive cases have been confirmed in Dakshina Kannada. With the recovery of one patient, there are 11 active cases in the district.

Mangaluru, May 23: Criticising the Karnataka government's fresh protocol for management of Covid-19 as expensive, a prominent physician in the city has demanded its withdrawal.

According to Dr B Srinivas Kakkilaya, the protocol released by the Health and Family Welfare Department on May 15 enlists unnecessary and unconfirmed tests and treatments. 

The protocol has classified Covid-19 cases into three categories and has provided for hospitalisation of all three categories of patients, from asymptomatic to the most severely ill.

In a letter to the government, Dr Kakkilaya said: "The protocol suggests several investigations to be done right on the day of admission, including blood counts, liver and renal function tests, chest X Ray, ECG, CT scan of the chest, and other special investigations, all of which, if done, will cost Rs 25,000 per patient."

"In the coming days when lakhs of patients are likely to be infected with SARS CoV2, is it necessary and feasible to hospitalise and test all these patients at Rs 25,000 per person," he questioned.

The treatment options suggested in the protocol are also surprising, he pointed out. "The protocol recommends choloroquine, azithromycin, oseltamivir, zinc and vitamin C for all patients, from asymptomatic to the severely ill, and also anti coagulant injections for many patients. All these would cost at least Rs 5,000 per patient. For severe cases of Covid-19, many unproven and experimental treatments have been suggested, which are very expensive and highly questionable," Dr Kakkilaya notes.

Therefore, this protocol, he asserted was not evidence based and likely to do more harm than good. He said these unnecessarily expensive tests and allowing private companies to conduct trials on Covid-19 patients is likely to be misused by vested interests and must be immediately withdrawn, and instead, a protocol that is evidence-based, simple and avoiding unnecessary expenses, must be developed.